KK
UPB

KLP Kapitalforvaltning’s Upstream Bio Inc UPB Stock Holding History

KLP Kapitalforvaltning’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8K Hold
5,900
– – ﹤0.01% 2132
2026
Q1 		$53.1K Buy
5,900
+3,000
+103% +$54K ﹤0.01% 2130
2025
Q4 		$78.7K Buy
+2,900
New +$72.2K ﹤0.01% 2116

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KLP Kapitalforvaltning's UPB Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Upstream Bio Inc (UPB) position steady in Q2 2026 at 5,900 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

KLP Kapitalforvaltning first reported a position in UPB in Q4 2025 and has held it in 3 quarters since. The position peaked at $78.7K in Q4 2025. 149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • KLP Kapitalforvaltning held 5,900 shares of Upstream Bio Inc worth $40.8K as of Q2 2026.
  • KLP Kapitalforvaltning left its Upstream Bio Inc share count unchanged in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2132 holding.
  • KLP Kapitalforvaltning first reported a position in Upstream Bio Inc in Q4 2025 and has held it in 3 quarters since.
  • KLP Kapitalforvaltning's Upstream Bio Inc position peaked at $78.7K in Q4 2025.
  • 149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.